Annual Total Long Term Liabilities
$8.78 M
-$1.45 M-14.19%
31 December 2023
Summary:
Theriva Biologics annual total long term liabilities is currently $8.78 million, with the most recent change of -$1.45 million (-14.19%) on 31 December 2023. During the last 3 years, it has risen by +$8.60 million (+4622.58%). TOVX annual total long term liabilities is now -16.34% below its all-time high of $10.50 million, reached on 01 December 2002.TOVX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$8.15 M
+$254.00 K+3.22%
01 September 2024
Summary:
Theriva Biologics quarterly total long term liabilities is currently $8.15 million, with the most recent change of +$254.00 thousand (+3.22%) on 01 September 2024. Over the past year, it has dropped by -$768.00 thousand (-8.61%). TOVX quarterly long term liabilities is now -34.37% below its all-time high of $12.42 million, reached on 01 September 2017.TOVX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TOVX Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.2% | -8.6% |
| 3 y3 years | +4622.6% | +480.9% |
| 5 y5 years | +1757.1% | +1623.0% |
TOVX Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -14.2% | +4622.6% | -20.4% | +480.9% |
| 5 y | 5 years | -14.2% | +4622.6% | -20.4% | +7446.3% |
| alltime | all time | -16.3% | -34.4% |
Theriva Biologics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.15 M(+3.2%) |
| June 2024 | - | $7.90 M(-8.2%) |
| Mar 2024 | - | $8.60 M(-2.1%) |
| Dec 2023 | $8.78 M(-14.2%) | $8.78 M(-1.5%) |
| Sept 2023 | - | $8.92 M(+4.2%) |
| June 2023 | - | $8.56 M(-1.4%) |
| Mar 2023 | - | $8.68 M(-15.2%) |
| Dec 2022 | $10.24 M(+629.7%) | $10.24 M(+39.2%) |
| Sept 2022 | - | $7.35 M(-0.5%) |
| June 2022 | - | $7.39 M(-26.0%) |
| Mar 2022 | - | $10.00 M(+612.5%) |
| Dec 2021 | $1.40 M(+654.3%) | - |
| Dec 2021 | - | $1.40 M(+0.1%) |
| Sept 2021 | - | $1.40 M(-1.8%) |
| June 2021 | - | $1.43 M(+1220.4%) |
| Mar 2021 | - | $108.00 K(-41.9%) |
| Dec 2020 | $186.00 K(-60.7%) | $186.00 K(-28.7%) |
| Sept 2020 | - | $261.00 K(-21.9%) |
| June 2020 | - | $334.00 K(-17.5%) |
| Mar 2020 | - | $405.00 K(-14.4%) |
| Dec 2019 | $473.00 K(+56.6%) | $473.00 K(-12.2%) |
| Sept 2019 | - | $539.00 K(-10.3%) |
| June 2019 | - | $601.00 K(-9.2%) |
| Mar 2019 | - | $662.00 K(+119.2%) |
| Dec 2018 | $302.00 K(-24.9%) | $302.00 K(-8.2%) |
| Sept 2018 | - | $329.00 K(-6.8%) |
| June 2018 | - | $353.00 K(-6.4%) |
| Mar 2018 | - | $377.00 K(-6.2%) |
| Dec 2017 | $402.00 K(-18.3%) | $402.00 K(-96.8%) |
| Sept 2017 | - | $12.42 M(+2671.9%) |
| June 2017 | - | $448.00 K(-4.7%) |
| Mar 2017 | - | $470.00 K(-4.5%) |
| Dec 2016 | $492.00 K(+84.3%) | $492.00 K(+129.9%) |
| Sept 2016 | - | $214.00 K(-5.7%) |
| June 2016 | - | $227.00 K(-5.4%) |
| Mar 2016 | - | $240.00 K(-10.1%) |
| Dec 2015 | $267.00 K(>+9900.0%) | $267.00 K(+34.8%) |
| Sept 2015 | - | $198.00 K(>+9900.0%) |
| June 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2014 | - | $0.00(0.0%) |
| June 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00 | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2013 | - | $0.00(0.0%) |
| June 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2012 | - | $0.00(0.0%) |
| June 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2011 | - | $2300.00(0.0%) |
| June 2011 | - | $2300.00(-86.7%) |
| Mar 2011 | - | $17.30 K(-45.9%) |
| Dec 2010 | $32.00 K(-69.8%) | $32.00 K(-70.7%) |
| Sept 2010 | - | $109.20 K(-13.7%) |
| June 2010 | - | $126.60 K(-10.5%) |
| Mar 2010 | - | $141.50 K(+33.7%) |
| Dec 2009 | $105.80 K(>+9900.0%) | $105.80 K(-39.6%) |
| Sept 2009 | - | $175.20 K(+43.3%) |
| June 2009 | - | $122.30 K(-10.9%) |
| Mar 2009 | - | $137.30 K(>+9900.0%) |
| Dec 2008 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2007 | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2007 | - | $600.00 K(+71.4%) |
| June 2007 | - | $350.00 K(-12.5%) |
| Mar 2007 | - | $400.00 K(-96.2%) |
| Dec 2005 | $0.00(-100.0%) | - |
| Mar 2003 | - | $10.50 M(0.0%) |
| Dec 2002 | $10.50 M(+110.0%) | $10.50 M(-8.7%) |
| Sept 2002 | - | $11.50 M(0.0%) |
| June 2002 | - | $11.50 M(+15.0%) |
| Mar 2002 | - | $10.00 M(+100.0%) |
| Dec 2001 | $5.00 M(+150.0%) | $5.00 M(+66.7%) |
| Sept 2001 | - | $3.00 M(+50.0%) |
| June 2001 | - | $2.00 M(0.0%) |
| Mar 2001 | - | $2.00 M(0.0%) |
| Dec 2000 | $2.00 M(0.0%) | $2.00 M(0.0%) |
| Sept 2000 | - | $2.00 M(0.0%) |
| June 2000 | - | $2.00 M(0.0%) |
| Mar 2000 | - | $2.00 M(0.0%) |
| Dec 1999 | $2.00 M(+100.0%) | $2.00 M(+33.3%) |
| June 1999 | - | $1.50 M(0.0%) |
| Mar 1999 | - | $1.50 M(+50.0%) |
| Dec 1998 | $1.00 M(-37.5%) | $1.00 M(+100.0%) |
| Sept 1998 | - | $500.00 K(-44.4%) |
| Mar 1998 | - | $900.00 K(-43.8%) |
| Dec 1997 | $1.60 M | $1.60 M(-11.1%) |
| Sept 1997 | - | $1.80 M |
FAQ
- What is Theriva Biologics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Theriva Biologics?
- What is Theriva Biologics annual total long term liabilities year-on-year change?
- What is Theriva Biologics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Theriva Biologics?
- What is Theriva Biologics quarterly long term liabilities year-on-year change?
What is Theriva Biologics annual total long term liabilities?
The current annual total long term liabilities of TOVX is $8.78 M
What is the all time high annual total long term liabilities for Theriva Biologics?
Theriva Biologics all-time high annual total long term liabilities is $10.50 M
What is Theriva Biologics annual total long term liabilities year-on-year change?
Over the past year, TOVX annual total long term liabilities has changed by -$1.45 M (-14.19%)
What is Theriva Biologics quarterly total long term liabilities?
The current quarterly long term liabilities of TOVX is $8.15 M
What is the all time high quarterly long term liabilities for Theriva Biologics?
Theriva Biologics all-time high quarterly total long term liabilities is $12.42 M
What is Theriva Biologics quarterly long term liabilities year-on-year change?
Over the past year, TOVX quarterly total long term liabilities has changed by -$768.00 K (-8.61%)